copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home | GSK US May 29 2025 GSK data at ASCO and EHA showcase latest research and innovation across the oncology portfolio May 22 2025 Nucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
Contact us - GSK GSK 2929 Walnut Street Ste 1700 Philadelphia, PA 19104 North Carolina Address: GSK 410 Blackwell St Durham, NC 27701 Patients GSK US Response Center - (prescription products) Contact us online Disaster
Company | GSK US We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally Learn more about our views and our practices across a range of issues that are important to GSK, our patients and our stakeholder s Our policy positions
Careers | GSK US At GSK, we unite science, technology and talent to get ahead of disease together We aim to positively impact the health of 2 5 billion people by the end of the decade, as a successful, growing company where people can thrive Close Video Explore US career opportunities
Products - GSK US Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations If you are a healthcare professional, you can access more product information on our GSKPro website In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center
ViiV Healthcare continues to deliver long-acting injectable HIV . . . GSK plc (LSE NYSE: GSK) announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will be presenting abstracts from its innovative HIV treatment and prevention portfolio and research pipeline at the Conference on Retroviruses and Opportunistic Infections (CROI 2025)
Locations | GSK US Trade marks are owned by or licensed to the GSK group of companies GSK plc Registered in England and Wales No 3888792 Registered office: 79 New Oxford Street, London United Kingdom WC1A 1DG GSK websites; GSK Global website; Locations selector; Global Behind the science; GSKPro for HCPs; ViiV Healthcare;
Press releases | GSK US GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education Download (PDF, 254 1KB) March 25 2025 Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and pediatric patients 12 years of age and older
GSK and Lifetime® launch original movie to raise awareness about the . . . Issued: Philadelphia PA GSK plc (LSE NYSE: GSK) today announced its sponsorship of Pretty Hurts, a gripping new Lifetime Original Movie and the latest extension of GSK’s Ask2BSure public health campaign Premiering on June 28, 2025, at 8 p m ET 7 p m CT, Pretty Hurts features a storyline that aims to raise awareness among parents about meningococcal disease, known as meningitis, an
Purpose, strategy and culture | GSK US GSK is a company where outstanding people can thrive We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat disease At the heart of this is our R D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in